Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice.
Open Access
- 1 August 1997
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 100 (3) , 558-564
- https://doi.org/10.1172/jci119565
Abstract
Lipoprotein(a) contributes to the development of atherosclerosis through the binding of its plasminogen-like apolipoprotein(a) component to fibrin and other plasminogen substrates. Apolipoprotein(a) contains a major lysine binding site in one of its kringle domains. Destruction of this site by mutagenesis greatly reduces the binding of apolipoprotein(a) to lysine and fibrin. Transgenic mice expressing this mutant form of apolipoprotein(a) as well as mice expressing wild-type apolipoprotein(a) have been created in an inbred mouse strain. The wild-type apolipoprotein(a) transgenic mice have a fivefold increase in the development of lipid lesions, as well as a large increase in the focal deposition of apolipoprotein(a) in the aorta, compared with the lysine binding site mutant strain and to nontransgenic littermates. The results demonstrate the key role of this lysine binding site in the pathogenic activity of apolipoprotein(a) in a murine model system.Keywords
This publication has 53 references indexed in Scilit:
- Optimization of immunofluorescence methods by quantitative image analysis.Journal of Histochemistry & Cytochemistry, 1996
- Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.Journal of Clinical Investigation, 1996
- Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged menThe American Journal of Cardiology, 1996
- Identification of Two Functionally Distinct Lysine-binding Sites in Kringle 37 and in Kringles 32−36 of Human Apolipoprotein(a)Published by Elsevier ,1995
- The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.Journal of Clinical Investigation, 1995
- Protein-ligand interactions in the lysine-binding site of plasminogen kringle 4 are different in crystal and solution. Electrostatic interactions studied by site-directed mutagenesis exclude Lys35 as an important acceptor in solutionBiochemistry, 1993
- Crystal and molecular structure of human plasminogen kringle 4 refined at 1.9-.ANG. resolutionBiochemistry, 1991
- Lipoprotein (a). Heterogeneity and biological relevance.Journal of Clinical Investigation, 1990
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987
- Studies on the Lysine-Binding Sites of Human Plasminogen. The Effect of Ligand Structure on the Binding of Lysine Analogs to PlasminogenEuropean Journal of Biochemistry, 1980